drugset / Trial / NCT02514577
Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is to evaluate the safety and efficacy of a topical lotion when applied once daily to adult participants with moderate to severe plaque psoriasis (defined as an Investigator's Global Assessment \[IGA\] score of 3 or 4).
Timeline
- Start
- 2015-11-07
- Primary completion
- 2017-05-01
- Completion
- 2017-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | halobetasol propionate | Small molecule | 0.01 % | Topical |